Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 1000

Metabolome profiling of S cerevisiae with drugs targeting receptors and enzymes

ABSTRACT: Saccharomyces cerevisiae were treated with drugs known to target receptors or enzymes within the yeast. Metabololite extracts were extracted and subjected to flow injection analysis.

INSTRUMENT(S): 6550 iFunnel Q-TOF LC/MS

ORGANISM(S): Saccharomyces Cerevisiae (ncbitaxon:4932)

SUBMITTER: Uwe Sauer

PROVIDER: MSV000088124 | MassIVE | Mon Sep 20 07:34:00 BST 2021

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

GNPS Metabolome profiling of S cerevisiae with drugs targeting receptors and enzymes

Project description:Saccharomyces cerevisiae were treated with drugs known to target receptors or enzymes within the yeast. Metabololite extracts were extracted and subjected to flow injection analysis.

| MSV000088124 | GNPS

Effect of putative GPR1 antagonists on the metabolome profile of Saccharomyces cerevisiae

Project description:Saccharomyces cerevisiae was treated with 10 uM of the indicated drugs for a duration of 30 minutes before the intracellular metabolome was collected. Samples were subjected to LCMS analysis in negative mode with separation by an InfinityLab Poroshell 120 HILIC-Z column (2.1 x 100 mm, 2.7 um, Agilent)

2021-05-13 | MSV000087420 | MassIVE

Strain abundance assay of barcoded heterozygous and homozygous yeast single gene deletion strains exposed to 87 psychoactive drugs

Project description:To profile off-target effects of psychoactive drugs, 87 genome-wide drug fitness assays (of which 5 were performed in duplicate) and 18 genome-wide control experiments were performed in Saccharomyces cerevisiae. Heterozygous and homozygous yeast single gene deletion strains from the BY collection of the Saccharomyces cerevisiae genome deletion consortium were used.

2008-07-07 | E-MTAB-34 | biostudies-arrayexpress

Expression data from Saccharomyces cerevisiae

Project description:Saccharomyces cerevisiae is an excellent microorganism for industrial succinic acid production, but high succinic acid concentration will inhibit the growth of Saccharomyces cerevisiae then reduce the production of succinic acid. Through analysis the transcriptomic data of Saccharomyces cerevisiae with different genetic backgrounds under different succinic acid stress, we hope to find the response mechanism of Saccharomyces cerevisiae to succinic acid.

2022-01-09 | GSE193190 | GEO

Expression data from Saccharomyces cerevisiae upon honokiol treatment

Project description:Honokiol (HNK), one of the main medicinal components in Magnolia officinalis, possesses antimicrobial activity against a variety of pathogenic bacteria and fungi.S. cerevisiae is a model eukaryote used for investigating the cellular and molecular mechanisms of anti-fungal drugs. To explore the molecular mechanism of its anti-fungal activity, we determined the effects of HNK on the mRNA expression profile of Saccharomyces cerevisiae using a DNA microarray approach.

2017-05-22 | GSE94945 | GEO

Transcription profiling of S. cerevisiae haploid deletion collection in the presence of drugs

Project description:Competitive growth of the S. cerevisiae haploid deletion collection in the presence of drugs

2008-10-21 | E-TABM-570 | biostudies-arrayexpress

Metabolome profiling of induced overexpression of S cerevisiae genes

Project description:Metabolite extracts were collected for 86 inducible overexpression strains in Saccharomyces cerevisiae in the presence and absence of inducer. Induction was carried out for 1.5 hours prior to metabolite extraction. Extracts were subjected to flow injection analysis.

2021-09-20 | MSV000088125 | MassIVE

Expression analysis of novel and known antifungal drugs using S. cerevisiae as a model

Project description:A systematic approach allowing the identification of the molecular way of action of novel potential drugs still represents the golden-tool for drug-discovery researchers. While high-throughput screening technologies of large libraries is now well established, the assessment of the drug targets and mechanism of action is still under development. Taking advantage of the yeast model Saccharomyces cerevisiae, we herein applied BarSeq, a Next Generation Sequencing based method to the analysis of both haploinsufficiency and homozygous fitness effects of a novel antifungal drug compared to the well-known antifungal, ketoconazole. Integrative bioinformatic analysis of BarSeq, whole genome expression analysis and classical biological assays identified the target and cell pathways affected by the novel antifungal. Confirmation of the effects observed in the yeast model as well as in pathogenic fungi further demonstrated the reliability of the multi-sided approach and the novelty of the targets and mode of action of the new class of molecules studied that thus represent a valuable source of novel antifungals.

2016-12-30 | GSE42418 | GEO

Array competitive genomic hybridization of three Saccharomyces cerevisiae strains vs. DBY8268

Project description:A six array study using total gDNA recovered from two separate cultures of each of three different strains of Saccharomyces cerevisiae (YB-210 or CRB, Y389 or MUSH, and Y2209 or LEP) and two separate cultures of Saccharomyces cerevisiae DBY8268. Each array measures the hybridization of probes tiled across the Saccharomyces cerevisiae genome.

2014-10-01 | GSE56441 | GEO

Expression data from Saccharomyces cerevisiae

Project description:Industrial bioethanol production may involve a low pH environment,improving the tolerance of S. cerevisiae to a low pH environment caused by inorganic acids may be of industrial importance to control bacterial contamination, increase ethanol yield and reduce production cost. Through analysis the transcriptomic data of Saccharomyces cerevisiae with different ploidy under low pH stress, we hope to find the tolerance mechanism of Saccharomyces cerevisiae to low pH.

2022-12-09 | GSE210964 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data